Study on bioequivalence of two nimodipine tablets by HPLC-MS
Zhu Sheng-ping
Abstract
Zhu Sheng-ping
Abstract
OBJECTIVE To evaluate the bioequivalence of two domestic nimodipine tablets. METHODS A single oral administration of 60 mg nimodipine tablets was given to 20 health y volunteers. Nimodipine concentrations in plasma were determined by HPLC-MS.RESULTS The main pharmacokinetic parameters of two nimodipine tablets were as follow: t 1/2( 2.1± 0.3),( 2.2± 0.4)h, t max ( 1.5 ± 0.4), ( 1.6± 0.4)h, C max ( 28.2± 7.1), ( 28.8± 7.6) μg·L -1, AUC ( 105.9± 29.5), ( 106.5± 26.4) μg·L -1·h respectively.The relative bioavailability of the test tablet was ( 99.4± 5.3)%.CONCLUSION The results has demonstrated that the two tablets are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To evaluate the bioequivalence of two domestic nimodipine tablets. METHODS A single oral administration of 60 mg nimodipine tablets was given to 20 health y volunteers. Nimodipine concentrations in plasma were determined by HPLC-MS.RESULTS The main pharmacokinetic parameters of two nimodipine tablets were as follow: t 1/2( 2.1± 0.3),( 2.2± 0.4)h, t max ( 1.5 ± 0.4), ( 1.6± 0.4)h, C max ( 28.2± 7.1), ( 28.8± 7.6) μg·L -1, AUC ( 105.9± 29.5), ( 106.5± 26.4) μg·L -1·h respectively.The relative bioavailability of the test tablet was ( 99.4± 5.3)%.CONCLUSION The results has demonstrated that the two tablets are bioequivalent.
Key concepts: Nimodipine, Bioequivalence, Bioavailability, Pharmacokinetics, High-performance liquid chromatography, Pharmacology, Chromatography, Plasma concentration